Denka Company Limited
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 6 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Dividend History 1Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥100 | +11.1% |
| 2024 | ¥90 | 0.0% |
| 2023 | ¥90 | -37.9% |
| 2022 | ¥145 | +7.4% |
| 2021 | ¥135 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥384,849M | ¥407,559M | ¥389,263M | ¥400,251M |
| Gross Profit | ¥107,175M | ¥102,342M | ¥82,501M | ¥84,595M |
| Operating Income | ¥40,124M | ¥32,325M | ¥13,377M | ¥14,413M |
| Pretax Income | ¥35,557M | ¥15,747M | ¥16,166M | -¥14,990M |
| Net Income | ¥26,012M | ¥12,768M | ¥11,947M | -¥12,300M |
| EPS | ¥301.67 | ¥148.08 | ¥138.61 | -¥142.73 |
| Operating Margin | 10.43% | 7.93% | 3.44% | 3.60% |
| Balance Sheet | ||||
| Total Assets | ¥557,640M | ¥592,151M | ¥616,239M | ¥655,517M |
| Total Equity | ¥288,470M | ¥296,479M | ¥307,536M | ¥296,181M |
| Total Liabilities | ¥269,170M | ¥295,672M | ¥308,703M | ¥359,336M |
| Cash | ¥20,210M | ¥20,199M | ¥35,386M | ¥37,002M |
| Interest-bearing Debt | ¥137,031M | ¥169,729M | ¥174,368M | ¥217,679M |
| Equity Ratio | 51.73% | 50.07% | 49.91% | 45.18% |
| D/E Ratio | 0.48 | 0.57 | 0.57 | 0.73 |
| Cash Flow | ||||
| Operating CF | ¥42,630M | ¥8,946M | ¥36,260M | ¥18,620M |
| Investing CF | -¥36,839M | -¥28,268M | -¥22,572M | -¥59,586M |
| Financing CF | -¥12,341M | ¥18,361M | ¥712M | ¥40,118M |
| Free CF | ¥4,676M | -¥30,894M | -¥8,419M | -¥41,210M |
| Efficiency | ||||
| ROE | 9.02% | 4.31% | 3.88% | -4.15% |
| ROA | 4.66% | 2.16% | 1.94% | -1.88% |
Latest IR Information
-
No IR information found for this company.
Searched stock code: 4061
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥3,167
Rating Score: 2.14 (Based on 6 analysts)
※1=Strong Buy, 5=Strong Sell
New simulator mimics real tissue for safer endoscopic cancer surgery training - Medical Xpress ↗
Company Information
About
Denka Company Limited manufactures and sells organic and inorganic, electronic material, pharmaceutical, and resin-related products in Japan, rest of Asia, and internationally. It operates through Electronic & Innovative Products; Life Innovation; Elastomers & Infrastructure Solutions; Polymer Solutions; and Other Business segments. The Electronic & Innovative Products segment manufactures and sells electronic packaging materials, fine and functional ceramics, fused silica, acetylene black, electronic circuit substrates, industrial tapes, functional films, spherical alumina, electrical constructional materials, adhesives, adhesive and electrical tapes, monosilane gas, and semiconductor processing materials. Its Life Innovation segment develops influenza vaccines, antigen testing kits, diagnostic reagents, and oncolytic virus agents. The Elastomers & Infrastructure Solutions segment produces functional elastomers, such as chloroprene rubber; cement; special cement additives; fire resistant and environmental materials; construction chemicals; alumina fibers; fused phosphate fertilizers, as well as humic acid magnesium and liquid fertilizers; calcium carbide; and polyethylene corrugated pipes. Its Polymer Solutions segment consisting of styrene monomers, polystyrene and ABS resins, transparent and heat-resistant resins, resins for shrink labels, food packaging sheets and films, synthetic fibers for wigs, POVAL, and CLEAREN. The Other Business segment engages in plant engineering and trading businesses. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Chuo, Japan.